FSCN1 and squamous carcinoma in situ: In our study fascin was widely detected in most invasive squamous cell carcinomas of the lung, though with variable immunostaining intensity, whereas the protein was scarcely expressed in in situ squamous cell carcinomas at different anatomical sites (cervix, larynx, lung, and skin; data not shown).